Virtus ETF Advisers LLC Amicus Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

  • $65.2 Million
  • Q2 2025

A detailed history of Virtus ETF Advisers LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 4,523 shares of FOLD stock, worth $38,174. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,523
Previous 18,652 75.75%
Holding current value
$38,174
Previous $152,000 83.55%
% of portfolio
0.04%
Previous 0.22%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$5.64 - $8.0 $79,687 - $113,032
-14,129 Reduced 75.75%
4,523 $25,000
Q1 2025

May 14, 2025
SELL
$8.16 - $9.85 $128,903 - $155,600
-15,797 Reduced 45.86%
18,652 $152,000
Q4 2024

Feb 14, 2025
BUY
$9.36 - $12.01 $32,853 - $42,155
3,510 Added 11.34%
34,449 $324,000
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $3,028 - $3,936
335 Added 1.09%
30,939 $306,000
Q1 2024

May 15, 2024
BUY
$11.43 - $14.24 $50,326 - $62,698
4,403 Added 16.8%
30,604 $360,000
Q4 2023

Feb 15, 2024
BUY
$9.97 - $14.52 $33,140 - $48,264
3,324 Added 14.53%
26,201 $371,000
Q3 2023

Nov 07, 2023
SELL
$11.78 - $13.86 $34,857 - $41,011
-2,959 Reduced 11.45%
22,877 $278,000
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $11,759 - $14,590
1,097 Added 4.43%
25,836 $324,000
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $4,778 - $5,930
438 Added 1.8%
24,739 $274,000
Q4 2022

Feb 14, 2023
SELL
$9.89 - $12.7 $53,376 - $68,541
-5,397 Reduced 18.17%
24,301 $296,000
Q3 2022

Nov 14, 2022
BUY
$9.82 - $12.75 $4,271 - $5,546
435 Added 1.49%
29,698 $310,000
Q2 2022

Aug 12, 2022
SELL
$6.23 - $11.12 $40,725 - $72,691
-6,537 Reduced 18.26%
29,263 $314,000
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $67,453 - $85,450
-6,869 Reduced 16.1%
35,800 $413,000
Q3 2021

Nov 15, 2021
SELL
$8.74 - $11.84 $34,147 - $46,258
-3,907 Reduced 8.39%
42,669 $407,000
Q2 2021

Aug 10, 2021
BUY
$8.71 - $10.72 $177,466 - $218,420
20,375 Added 77.76%
46,576 $449,000
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $6,568 - $17,036
714 Added 2.8%
26,201 $259,000
Q4 2020

Feb 12, 2021
SELL
$13.47 - $24.89 $376,984 - $696,596
-27,987 Reduced 52.34%
25,487 $588,000
Q3 2020

Nov 13, 2020
BUY
$12.89 - $15.89 $58,056 - $71,568
4,504 Added 9.2%
53,474 $755,000
Q2 2020

Aug 05, 2020
SELL
$8.86 - $15.69 $118,954 - $210,653
-13,426 Reduced 21.52%
48,970 $738,000
Q1 2020

May 14, 2020
SELL
$6.63 - $11.16 $34,906 - $58,757
-5,265 Reduced 7.78%
62,396 $577,000
Q4 2019

Feb 13, 2020
BUY
$7.48 - $10.75 $49,427 - $71,036
6,608 Added 10.82%
67,661 $659,000
Q3 2019

Nov 12, 2019
SELL
$8.02 - $13.25 $82,341 - $136,037
-10,267 Reduced 14.4%
61,053 $490,000
Q2 2019

Aug 13, 2019
SELL
$10.96 - $14.4 $25,569 - $33,595
-2,333 Reduced 3.17%
71,320 $890,000
Q1 2019

May 14, 2019
BUY
$10.04 - $13.92 $162,909 - $225,865
16,226 Added 28.26%
73,653 $1 Million
Q4 2018

Feb 05, 2019
BUY
$8.38 - $13.44 $239,517 - $384,142
28,582 Added 99.09%
57,427 $550,000
Q3 2018

Nov 14, 2018
SELL
$11.6 - $16.54 $239,076 - $340,889
-20,610 Reduced 41.67%
28,845 $349,000
Q2 2018

Aug 10, 2018
SELL
$13.13 - $17.09 $123,172 - $160,321
-9,381 Reduced 15.94%
49,455 $772,000
Q1 2018

May 14, 2018
BUY
$13.76 - $17.12 $434,747 - $540,906
31,595 Added 115.98%
58,836 $885,000
Q4 2017

Feb 14, 2018
SELL
$12.51 - $16.24 $137,384 - $178,347
-10,982 Reduced 28.73%
27,241 $392,000
Q3 2017

Nov 14, 2017
BUY
$11.74 - $15.78 $41,043 - $55,166
3,496 Added 10.07%
38,223 $576,000
Q2 2017

Aug 14, 2017
BUY
N/A
34,727
34,727 $350,000

Others Institutions Holding FOLD

# of Institutions
301
Shares Held
331M
Call Options Held
396K
Put Options Held
249K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.37B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email